Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term
Open accessAbstract
Parkinson's disease is characterized by degeneration of substantia nigra dopamine neurons and by intraneuronal aggregates, primarily composed of misfolded α-synuclein. The α-synuclein aggregates in Parkinson's patients are suggested to first appear in the olfactory bulb and enteric nerves and then propagate, following a stereotypic pattern, via neural pathways to numerous regions across the brain. We recently demonstrated that after injection of either mouse or human α-synuclein fibrils into the olfactory bulb of wild-type mice, α-synuclein fibrils recruited endogenous α-synuclein into pathological aggregates that spread transneuronally to over 40 other brain regions and subregions, over 12 months. We previously reported the progressive spreading of α-synuclein aggregates, between 1 and 12 months following α-synuclein fibril injections, and now report how far the pathology has spread 18- and 23-month post-injection in this model. Our data show that between 12 and 18 months, there is a further increase in the number of brain regions exhibiting pathology after human, and to a lesser extent mouse, α-synuclein fibril injections. At both 18 and 23 months after injection of mouse and human α-synuclein fibrils, we observed a reduction in the density of α-synuclein aggregates in some brain regions compared to others at 12 months. At 23 months, no additional brain regions exhibited α-synuclein aggregates compared to earlier time points. In addition, we also demonstrate that the induced α-synucleinopathy triggered a significant early neuron loss in the anterior olfactory nucleus. By contrast, there was no loss of mitral neurons in the olfactory bulb, even at 18 month post-injection. We speculate that the lack of continued progression of α-synuclein pathology is due to compromise of the neural circuitry, consequential to neuron loss and possibly to the activation of proteolytic mechanisms in resilient neurons of wild-type mice that counterbalances the spread and seeding by degrading pathogenic α-synuclein.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,706 · see citing works
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689 · see citing works
Cellular Scaling Rules for the Brains of Marsupials: Not as “Primitive” as Expected
Santos, S. E. D., Porfírio, J., Cunha, F., Manger, P. R., Tavares, W. C., Pessôa, L. M., Raghanti, M. A., Sherwood, C. C., & Herculano‐Houzel, S. (2017) · Brain Behavior and Evolution · doi:10.1159/000452856 · Cited by 2,651 · see citing works
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563 · see citing works
Self-citationNeuN, a neuronal specific nuclear protein in vertebratesxs
Mullen, R. J., Buck, C. R., & Smith, A. M. (1992) · Development · doi:10.1242/dev.116.1.201 · Cited by 2,351 · see citing works
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 1,906 · see citing works
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683 · see citing works
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591 · see citing works
Differential projections of the infralimbic and prelimbic cortex in the rat
Vertes, R. P. (2004) · Synapse · doi:10.1002/syn.10279 · Cited by 1,550 · see citing works
Alpha-synuclein and neurodegenerative diseases
Goedert, M. (2001) · Nature reviews. Neuroscience · doi:10.1038/35081564 · Cited by 1,402 · see citing works
New roles for astrocytes: redefining the functional architecture of the brain.
Nedergaard, M., Ransom, B., & Goldman, S. A. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.08.008 · Cited by 1,334 · see citing works
Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · see citing works
ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA
Rasband, W. S. (2011) · Medical Entomology and Zoology · Cited by 1,223 · see citing works
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
Peelaerts, W., Bousset, L., Van der Perren, A., Moskalyuk, A., Pulizzi, R., Giugliano, M., Van den Haute, C., Melki, R., & Baekelandt, V. (2015) · Nature · doi:10.1038/nature14547 · Cited by 1,130 · see citing works
Luk, K. C., Kehm, V. M., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M. ‐. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20112457 · Cited by 1,087 · see citing works
Self-citationPrion-like spreading of pathological α-synuclein in brain
Masuda-Suzukake, M., Nonaka, T., Hosokawa, M., Oikawa, T., Arai, T., Akiyama, H., Mann, D. M. A., & Hasegawa, M. (2013) · Brain · doi:10.1093/brain/awt037 · Cited by 867 · see citing works
Herculano‐Houzel, S. (2014) · Glia · doi:10.1002/glia.22683 · Cited by 731 · see citing works
Volpicelli-Daley, L. A., Luk, K. C., & Lee, V. M.-Y. (2014) · Nature Protocols · doi:10.1038/nprot.2014.143 · Cited by 731 · see citing works
Self-citationthe Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Lue, L., Sue, L. I., Bachalakuri, J., Henry-Watson, J., Sasse, J., Boyer, S., Shirohi, S., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0538-8 · Cited by 698 · see citing works
THE BIOCHEMISTRY OF PARKINSON'S DISEASE
Cookson, M. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133400 · Cited by 659 · see citing works
Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases
Guo, J. L., & Lee, V. M. Y. (2014) · Nature Medicine · doi:10.1038/nm.3457 · Cited by 641 · see citing works
Self-citationRecasens, A., Dehay, B., Bové, J., Carballo‐Carbajal, I., Doveró, S., Pérez‐Villalba, A., Fernagut, P., Blesa, J., Parent, A., Perier, C., et al. (2013) · Annals of Neurology · doi:10.1002/ana.24066 · Cited by 629 · see citing works
Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease
Postuma, R. B., Aarsland, D., Barone, P., Burn, D. J., Hawkes, C. H., Oertel, W. H., & Ziemssen, T. (2012) · Movement Disorders · doi:10.1002/mds.24996 · Cited by 615 · see citing works
Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
Goedert, M., Jakes, R., & Vanmechelen, E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11484-e · Cited by 608 · see citing works
Neumann, M., Kwong, L. K., Lee, E. B., Kremmer, E., Flatley, A., Xu, Y., Forman, M. S., Troost, D., Kretzschmar, H. A., Trojanowski, J. Q., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0477-9 · Cited by 604 · see citing works
Self-citationIrwin, D. J., Grossman, M., Weintraub, D. A., Hurtig, H. I., Duda, J. E., Xie, S. X., Lee, E. B., Deerlin, V. M. V., López, O. L., Kofler, J., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30291-5 · Cited by 588 · see citing works
Self-citationKrueger, C., & Tian, L. (2004) · Biological Research For Nursing · doi:10.1177/1099800404267682 · Cited by 561 · see citing works
NeuN: a useful neuronal marker for diagnostic histopathology.
Wolf, H. K., Buslei, R., Schmidt‐Kastner, R., Schmidt-Kastner, P. K., Pietsch, T., Wiestler, O. D., & Blümcke, I. (1996) · Journal of Histochemistry & Cytochemistry · doi:10.1177/44.10.8813082 · Cited by 526 · see citing works
Disease‐specific patterns of locus coeruleus cell loss
German, D. C., Manaye, K. F., White, C. L., Woodward, D. J., McIntire, D. D., Smith, W. K., Kalaria, R. N., & Mann, D. M. A. (1992) · Annals of Neurology · doi:10.1002/ana.410320510 · Cited by 512 · see citing works
NeuN As a Neuronal Nuclear Antigen and Neuron Differentiation Marker
Gusel’nikova, V. V., & Korzhevskiy, D. E. (2015) · Acta Naturae · doi:10.32607/20758251-2015-7-2-42-47 · Cited by 487 · see citing works
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases
Nakashima-Yasuda, H., Uryu, K., Robinson, J., Xie, S. X., Hurtig, H., Duda, J. E., Arnold, S. E., Siderowf, A., Grossman, M., Leverenz, J. B., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0261-2 · Cited by 468 · see citing works
Self-citationKaufman, S. K., Sanders, D. W., Thomas, T. L., Ruchinskas, A. J., Vaquer-Alicea, J., Sharma, A. M., Miller, T. M., & Diamond, M. I. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.055 · Cited by 450 · see citing works
Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease
Harding, A. J., Stimson, E., Henderson, J. M., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf251 · Cited by 445 · see citing works
Review: Sporadic Parkinson's disease: development and distribution ofα‐synuclein pathology
Tredici, K. D., & Braak, H. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12298 · Cited by 396 · see citing works
Rey, N. L., Steiner, J. A., Maroof, N., Luk, K. C., Madaj, Z., Trojanowski, J. Q., Lee, V. M. ‐., & Brundin, P. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160368 · Cited by 389 · see citing works
Self-citationPaumier, K. L., Luk, K. C., Manfredsson, F. P., Kanaan, N. M., Lipton, J. W., Collier, T. J., Steece‐Collier, K., Kemp, C. J., Celano, S. L., Schulz, E., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.003 · Cited by 386 · see citing works
Self-citationPrion-like acceleration of a synucleinopathy in a transgenic mouse model
Mougenot, A.-L. J., Nicot, S., Bencsik, A. A., Morignat, E., Verchère, J., Lakhdar, L., Legastelois, S., & Baron, T. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.06.022 · Cited by 375 · see citing works
Oueslati, A. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-160779 · Cited by 375 · see citing works
Sacino, A. N., Brooks, M., Thomas, M. A., McKinney, A. B., Lee, S., Regenhardt, R. W., McGarvey, N. H., Ayers, J. I., Notterpek, L. M., Borchelt, D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321785111 · Cited by 328 · see citing works
Sarnat, H. B., Nochlin, D., & Born, D. E. (1998) · Brain and Development · doi:10.1016/s0387-7604(97)00111-3 · Cited by 308 · see citing works
Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship
Xilouri, M., Brekk, O. R., & Stefanis, L. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8341-2 · Cited by 299 · see citing works
The anterior olfactory nucleus in Parkinson's disease
Pearce, R. K. B., Hawkes, C. H., & Daniel, S. E. (1995) · Movement Disorders · doi:10.1002/mds.870100309 · Cited by 289 · see citing works
Loría, F., Vargas, J., Bousset, L., Syan, S., Salles, A., Melki, R., & Zurzolo, C. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1746-2 · Cited by 278 · see citing works
Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice
Rey, N. L., Petit, G. H., Bousset, L., Melki, R., & Brundin, P. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1160-3 · Cited by 267 · see citing works
Self-citationIs Parkinson's disease a prion disorder?
Olanow, C. W., & Prusiner, S. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906759106 · Cited by 266 · see citing works
The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases
Rey, N. L., Wesson, D. W., & Brundin, P. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.013 · Cited by 257 · see citing works
Self-citationPathological alpha-synuclein propagates through neural networks
Masuda‐Suzukake, M., Nonaka, T., Hosokawa, M., Kubo, M., Shimozawa, A., Akiyama, H., & Hasegawa, M. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0088-8 · Cited by 249 · see citing works
Osterberg, V. R., Spinelli, K. J., Weston, L. J., Luk, K. C., Woltjer, R. L., & Unni, V. K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.060 · Cited by 240 · see citing works
Self-citationNeurons and circuits for odor processing in the piriform cortex
Bekkers, J. M., & Suzuki, N. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.04.005 · Cited by 238 · see citing works
Toledo, J. B., Van Deerlin, V. M., Lee, E. B., Suh, E., Baek, Y., Robinson, J. L., Xie, S. X., McBride, J., Wood, E. M., Schuck, T., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.06.003 · Cited by 234 · see citing works
Self-citationA field guide to the anterior olfactory nucleus (cortex)
Brunjes, P. C., Illig, K. R., & Meyer, E. A. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.08.005 · Cited by 224 · see citing works
Glia and alpha-synuclein in neurodegeneration: A complex interaction
Brück, D., Wenning, G. K., Stefanova, N., & Fellner, L. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.03.003 · Cited by 202 · see citing works
Toledo, J. B., Gopal, P., Raible, K., Irwin, D. J., Brettschneider, J., Sedor, S., Waits, K., Boluda, S., Grossman, M., Van Deerlin, V. M., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1526-9 · Cited by 184 · see citing works
Self-citationThe relation between α-synuclein and microglia in Parkinson’s disease: Recent developments
Sánchez-Guajardo, V., Tentillier, N., & Romero‐Ramos, M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.008 · Cited by 171 · see citing works
Olfactory Impairment Predicts Brain Atrophy in Parkinson's Disease: Figure 1.
Wattendorf, E., Welge–Lüssen, A., Fiedler, K., Bilecen, D., Wolfensberger, M., Fuhr, P., Hummel, T. R., & Westermann, B. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1909-09.2009 · Cited by 152 · see citing works
Sacino, A. N., Brooks, M., McKinney, A. B., Thomas, M. A., Shaw, G., Golde, T. E., & Giasson, B. I. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2102-14.2014 · Cited by 141 · see citing works
Neuropathology of α‐synuclein propagation and braak hypothesis
McCann, H., Cartwright, H., & Halliday, G. M. (2015) · Movement Disorders · doi:10.1002/mds.26421 · Cited by 132 · see citing works
Tapias, V., Hu, X., Luk, K. C., Sanders, L. H., Lee, V. M., & Greenamyre, J. T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2541-x · Cited by 126 · see citing works
Self-citationExperimental transmissibility of mutant SOD1 motor neuron disease
Ayers, J. I., Fromholt, S., Koch, M., DeBosier, A., McMahon, B., Xu, G. M., & Borchelt, D. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1342-7 · Cited by 123 · see citing works
Parkinson’s disease: a review of non-motor symptoms
Rana, A. Q., Ahmed, U. S., Chaudry, Z. M., & Vasan, S. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1038244 · Cited by 122 · see citing works
Alpha‐synuclein propagation: New insights from animal models
Dehay, B., Vila, M., Bézard, E., Brundin, P., & Kordower, J. H. (2015) · Movement Disorders · doi:10.1002/mds.26370 · Cited by 118 · see citing works
Self-citationAmyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice
Sacino, A. N., Brooks, M., Thomas, M. A., McKinney, A. B., McGarvey, N. H., Rutherford, N. J., Ceballos‐Diaz, C., Robertson, J., Golde, T. E., & Giasson, B. I. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1268-0 · Cited by 115 · see citing works
-Syn Suppression Reverses Synaptic and Memory Defects in a Mouse Model of Dementia with Lewy Bodies
Lim, Y., Kehm, V. M., Lee, E. B., Soper, J. H., Li, C., Trojanowski, J. Q., & Lee, V. M. Y. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0618-11.2011 · Cited by 113 · see citing works
Self-citationα‐Synuclein: The Long Distance Runner
George, S., Rey, N. L., Reichenbach, N., Steiner, J. A., & Brundin, P. (2013) · Brain Pathology · doi:10.1111/bpa.12046 · Cited by 108 · see citing works
Self-citationAyers, J. I., Brooks, M., Rutherford, N. J., Howard, J. K., Sorrentino, Z. A., Riffe, C. J., & Giasson, B. I. (2016) · Journal of Virology · doi:10.1128/jvi.02095-16 · Cited by 94 · see citing works
El‐Agnaf, O. M. A., & Irvine, G. B. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4262 · Cited by 91 · see citing works
Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein
Sacino, A. N., Brooks, M., McGarvey, N. H., McKinney, A. B., Thomas, M. A., Levites, Y., Ran, Y., Golde, T. E., & Giasson, B. I. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-38 · Cited by 86 · see citing works
Lamberts, J. T., Hildebrandt, E. N., & Brundin, P. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.002 · Cited by 74 · see citing works
Self-citationLavezzi, A. M., Corna, M. F., & Matturri, L. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.03.012 · Cited by 71 · see citing works
Rey, N. L., George, S., & Brundin, P. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12299 · Cited by 64 · see citing works
Self-citationNon-motor Symptoms of Parkinson's Disease
Hou, J. G., & Lai, E. C. (2007) · International journal of gerontology · doi:10.1016/s1873-9598(08)70024-3 · Cited by 63 · see citing works
Diversity among principal and GABAergic neurons of the anterior olfactory nucleus
Kay, R. B., & Brunjes, P. C. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00111 · Cited by 37 · see citing works
Olfactory performance acts as a cognitive reserve in non-demented patients with Parkinson's disease
Lee, J. E., Cho, K. H., Ham, J. H., Song, S., Sohn, Y. H., & Lee, P. H. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.10.024 · Cited by 31 · see citing works
Tanık, N., Serin, H. İ., Çelikbilek, A., İnan, L. E., & Gündoğdu, F. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.03.050 · Cited by 30 · see citing works
Neurogenesis in the anterior olfactory nucleus and its associated transition areas in the rat brain
Bayer, S. A. (1986) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(86)90062-6 · Cited by 29 · see citing works
Age-related change of neuropeptide Y-immunoreactive neurons in the rat anterior olfactory nucleus
Hwang, I. K., Kang, T., Park, S.-K., An, S.-J., Suh, J., Lee, J. Y., Lee, I. S., Yoon, Y., Oh, Y., & Won, M. H. (2001) · Journal of Neurocytology · doi:10.1023/a:1021880405862 · Cited by 13 · see citing works
Nuclear Protein NeuN in Neurons in the Human Substantia Nigra
Sukhorukova, E. G. (2014) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-014-9947-9 · Cited by 9 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [70]Toledo JB Gopal P Raible K Irwin DJ Brettschneider J Sedor S Waits K Boluda S Grossman M Van Deerlin VM Lee EB Arnold SE Duda JE Hurtig H Lee VMY Adler CH Beach TG Trojanowski JQ 2016 Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathology Acta Neuropathologica 131 393 409 10.1007/s00401-015-1526-9 26721587 PMC4754135 · DOI · Paper page
Cited by
Sorted by citations
Selective neuronal vulnerability in Parkinson disease
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,120 · see citing works
Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
Gómez-Benito, M., Granado, N., García‐Sanz, P., Michel, A., Dumoulin, M., & Moratalla, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00356 · Cited by 445 · see citing works
Uemura, N., Yagi, H., Uemura, M. T., Hatanaka, Y., Yamakado, H., & Takahashi, R. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0257-5 · Cited by 328 · see citing works
Henderson, M. X., Cornblath, E. J., Darwich, A., Zhang, B., Brown, H., Gathagan, R. J., Sandler, R. M., Bassett, D. S., Trojanowski, J. Q., & Lee, V. M. Y. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0457-5 · Cited by 310 · see citing works
Self-citationα-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies
Henderson, M. X., Trojanowski, J. Q., & Lee, V. M. ‐. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134316 · Cited by 291 · see citing works
Self-citationInitiation and propagation of α-synuclein aggregation in the nervous system
Hijaz, B. A., & Volpicelli‐Daley, L. A. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00368-6 · Cited by 267 · see citing works
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies
Bellomo, G., Luca, C. M. G. D., Paoletti, F. P., Gaetani, L., Moda, F., & Parnetti, L. (2022) · Neurology · doi:10.1212/wnl.0000000000200878 · Cited by 160 · see citing works
Cell-to-Cell Transmission of Tau and α-Synuclein
Uemura, N., Uemura, M. T., Luk, K. C., Lee, V. M. ‐., & Trojanowski, J. Q. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.03.012 · Cited by 141 · see citing works
Self-citationAlpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
Brás, I. C., & Outeiro, T. F. (2021) · Cells · doi:10.3390/cells10020375 · Cited by 136 · see citing works
CNS implications of COVID-19: a comprehensive review
Nagu, P., Parashar, A., Behl, T., & Mehta, V. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0070 · Cited by 131 · see citing works
Local vulnerability and global connectivity jointly shape neurodegenerative disease propagation
Zheng, Y., Zhang, Y., Yau, Y. H. C., Zeighami, Y., Larcher, K. M.-H., Mišić, B., & Dagher, A. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000495 · Cited by 116 · see citing works
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Úbeda‐Bañón, I., Saiz‐Sánchez, D., Flores‐Cuadrado, A., Corroto, E. R., González-Rodríguez, M., Villar‐Conde, S., Astillero‐Lopez, V., Cabello, J. P., Gallardo‐Alcañiz, M. J., Vaamonde‐Gamo, J., et al. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00200-7 · Cited by 129 · see citing works
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Tofaris, G. K. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04240-2 · Cited by 121 · see citing works
Modeling α-Synuclein Propagation with Preformed Fibril Injections
Chung, H. K., Ho, H.-A., Pérez-Acuña, D., & Lee, S. (2019) · Journal of Movement Disorders · doi:10.14802/jmd.19046 · Cited by 117 · see citing works
Rey, N. L., Bousset, L., George, S., Madaj, Z., Meyerdirk, L. K., Schulz, E., Steiner, J. A., Melki, R., & Brundin, P. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0859-3 · Cited by 116 · see citing works
Self-citationThe Vicious Cycle Between α ‐Synuclein Aggregation and Autophagic‐Lysosomal Dysfunction
Bellomo, G., Paciotti, S., Gatticchi, L., & Parnetti, L. (2019) · Movement Disorders · doi:10.1002/mds.27895 · Cited by 114 · see citing works
Alpha Synuclein: Neurodegeneration and Inflammation
Forloni, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065914 · Cited by 111 · see citing works
The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson’s disease
Vargas, J., Grudina, C., & Zurzolo, C. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.01.012 · Cited by 106 · see citing works
Wu, Q., Takano, H., Riddle, D. M., Trojanowski, J. Q., Coulter, D. A., & Lee, V. M. ‐. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0060-19.2019 · Cited by 106 · see citing works
Self-citationLysosomal exocytosis releases pathogenic α-synuclein species from neurons in synucleinopathy models
Xie, Y. X., Naseri, N. N., Fels, J. A., Kharel, P., Na, Y., Lane, D., Burré, J., & Sharma, M. (2022) · Nature Communications · doi:10.1038/s41467-022-32625-1 · Cited by 107 · see citing works
Mezias, C., Rey, N. L., Brundin, P., & Raj, A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104623 · Cited by 106 · see citing works
Self-citationDeterminants of seeding and spreading of α-synuclein pathology in the brain
Henrich, M. T., Geibl, F. F., Harini, L., Stegmann, A., Giasson, B. I., Mao, X., Dawson, V. L., Dawson, T. M., Oertel, W. H., & Surmeier, D. J. (2020) · Science Advances · doi:10.1126/sciadv.abc2487 · Cited by 101 · see citing works
Bantle, C. M., Phillips, A. T., Smeyne, R. J., Rocha, S. M., Olson, K. E., & Tjalkens, R. B. (2019) · npj Parkinson's Disease · doi:10.1038/s41531-019-0090-8 · Cited by 89 · see citing works
Okuzumi, A., Kurosawa, M., Hatano, T., Takanashi, M., Shuuko, N., Fukuhara, T., Yamanaka, T., Miyazaki, H., Yoshinaga, S., Furukawa, Y., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0587-0 · Cited by 87 · see citing works
Courte, J., Bousset, L., von Boxberg, Y., Villard, C., Melki, R., & Peyrin, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-61757-x · Cited by 80 · see citing works
Uemura, N., Uemura, M. T., Lo, A., Bassil, F., Zhang, B., Luk, K. C., Lee, V. M. ‐., Takahashi, R., & Trojanowski, J. Q. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz070 · Cited by 81 · see citing works
Self-citationRocha, S. M., Bantle, C. M., Aboellail, T., Chatterjee, D., Smeyne, R. J., & Tjalkens, R. B. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105685 · Cited by 83 · see citing works
Selective neuronal vulnerability in Parkinson's disease
González‐Rodríguez, P., Zampese, E., & Surmeier, D. J. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.02.005 · Cited by 75 · see citing works
Stoyka, L. E., Arrant, A. E., Thrasher, D. R., Russell, D. L., Freire, J., Mahoney-Crane, C. L., Narayanan, A., Dib, A. G., Standaert, D. G., & Volpicelli‐Daley, L. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104708 · Cited by 74 · see citing works
COVID-19: dealing with a potential risk factor for chronic neurological disorders
Schirinzi, T., Landi, D., & Liguori, C. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10131-y · Cited by 76 · see citing works
Aging-associated sensory decline and Alzheimer’s disease
Hong, S., Baek, S.-H., Lai, M. K. P., Arumugam, T. V., & Jo, D.-G. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00776-y · Cited by 76 · see citing works
Animal models of brain-first and body-first Parkinson's disease
Berge, N. V. D., & Ulusoy, A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105599 · Cited by 78 · see citing works
Graham, S. F., Rey, N. L., Yılmaz, A., Kumar, P., Madaj, Z., Maddens, M. E., Bahado-Singh, R. O., Becker, K., Schulz, E., Meyerdirk, L. K., et al. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00224 · Cited by 71 · see citing works
Self-citationAntibodies against alpha‐synuclein: tools and therapies
Vaikath, N. N., Hmila, I., Gupta, V. R., Erskine, D., Ingelsson, M., & El‐Agnaf, O. M. A. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14713 · Cited by 71 · see citing works
Organotypic slice culture model demonstrates inter-neuronal spreading of alpha-synuclein aggregates
Elfarrash, S., Jensen, N. M., Ferreira, N., Betzer, C., Thevathasan, J. V., Diekmann, R., Adel, M., Omar, N. M., Boraie, M. Z., Gad, S., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0865-5 · Cited by 70 · see citing works
Animal Model for Prodromal Parkinson’s Disease
Taguchi, T., Ikuno, M., Yamakado, H., & Takahashi, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061961 · Cited by 70 · see citing works
Differentially targeted seeding reveals unique pathological alpha-synuclein propagation patterns
Rahayel, S., Mišić, B., Zheng, Y., Liu, Z.-Q., Abdelgawad, A. A., Abbasi, N., Caputo, A., Zhang, B., Lo, A., Kehm, V. M., et al. (2021) · Brain · doi:10.1093/brain/awab440 · Cited by 64 · see citing works
Self-citationImmunotherapy in Parkinson’s disease: Current status and future directions
Chatterjee, D., & Kordower, J. H. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104587 · Cited by 68 · see citing works
Johnson, M., Bergkvist, L., Mercado, G., Stetzik, L. A., Meyerdirk, L. K., Wolfrum, E., Madaj, Z., Brundin, P., & Wesson, D. W. (2020) · Scientific Reports · doi:10.1038/s41598-020-66201-8 · Cited by 67 · see citing works
Self-citationSchaser, A. J., Stackhouse, T. L., Weston, L. J., Kerstein, P. C., Osterberg, V. R., López, C. S., Dickson, D. W., Luk, K. C., Meshul, C. K., Woltjer, R. L., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01026-0 · Cited by 62 · see citing works
Self-citationHenrich, M. T., Geibl, F. F., Lee, B., Chiu, W., Koprich, J. B., Brotchie, J. M., Timmermann, L., Decher, N., Matschke, L. A., & Oertel, W. H. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0541-1 · Cited by 65 · see citing works
Mavroeidi, P., Arvanitaki, F., Karakitsou, A.-K., Vetsi, M., Kloukina, I., Zweckstetter, M., Giller, K., Becker, S., Sorrentino, Z. A., Giasson, B. I., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02014-y · Cited by 64 · see citing works
Thomsen, M. B., Ferreira, S. A., Schacht, A. C., Jacobsen, J., Simonsen, M., Betzer, C., Jensen, P. H., Brooks, D. J., Landau, A. M., & Romero‐Ramos, M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105229 · Cited by 62 · see citing works
Multiple system atrophy: at the crossroads of cellular, molecular and genetic mechanisms
Stefanova, N., & Wenning, G. K. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00697-7 · Cited by 62 · see citing works
α ‐Synuclein Spread from Olfactory Bulb Causes Hyposmia, Anxiety, and Memory Loss in BAC‐ SNCA Mice
Uemura, N., Ueda, J., Yoshihara, T., Ikuno, M., Uemura, M. T., Yamakado, H., Asano, M., Trojanowski, J. Q., & Takahashi, R. (2021) · Movement Disorders · doi:10.1002/mds.28512 · Cited by 61 · see citing works
Self-citationMetabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson’s Disease
Graham, S. F., Rey, N. L., Ugur, Z., Yilmaz, A., Sherman, E., Maddens, M., Bahado-Singh, R. O., Becker, K., Schulz, E., Meyerdirk, L. K., et al. (2018) · Metabolites · doi:10.3390/metabo8040071 · Cited by 60 · see citing works
Self-citationReyes, J. F., Ekmark-Léwen, S., Perdiki, M., Klingstedt, T., Hoffmann, A., Wiechec, E., Nilsson, P., Nilsson, K. P. R., Alafuzoff, I., Ingelsson, M., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01136-3 · Cited by 59 · see citing works
Back and to the Future: From Neurotoxin‐Induced to Human Parkinson's Disease Models
Airavaara, M., Parkkinen, I., Konovalova, J., Albert, K., Chmielarz, P., & Domanskyi, A. (2020) · Current Protocols in Neuroscience · doi:10.1002/cpns.88 · Cited by 61 · see citing works
Merchant, K., Cedarbaum, J. M., Brundin, P., Dave, K. D., Eberling, J. L., Espay, A. J., Hutten, S. J., Javidnia, M., Luthman, J., Maetzler, W., et al. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181471 · Cited by 58 · see citing works
Self-citationPrion-Like Proteins in Phase Separation and Their Link to Disease
Sprunger, M. L., & Jackrel, M. E. (2021) · Biomolecules · doi:10.3390/biom11071014 · Cited by 57 · see citing works
Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein
Guan, Y., Zhao, X., Liu, F., Yan, S., Wang, Y., Du, C., Cui, X., Li, R., & Zhang, C. X. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00159 · Cited by 54 · see citing works
Brain atrophy in prodromal synucleinopathy is shaped by structural connectivity and gene expression
Rahayel, S., Tremblay, C., Vo, A., Zheng, Y. Q., Lehéricy, S., Arnulf, I., Vidailhet, M., Corvol, J., ICEBERG Study Group, Vidailhet, M., et al. (2022) · Brain · doi:10.1093/brain/awac187 · Cited by 55 · see citing works
Parkinson's Disease: Risk Factor Modification and Prevention
Rajan, S. M., & Kaas, B. M. (2022) · Seminars in Neurology · doi:10.1055/s-0042-1758780 · Cited by 55 · see citing works
Brain regions susceptible to alpha-synuclein spreading
Guo, Y., Xiong, H., Chen, K., Zou, J.-J., & Lei, P. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01296-7 · Cited by 53 · see citing works
Miquel-Rio, L., Alarcón-Arís, D., Torres‐López, M., Cóppola-Segovia, V., Pavia-Collado, R., Paz, V., Ruiz‐Bronchal, E., Campa, L., Casal, C., Montefeltro, A., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01842-z · Cited by 54 · see citing works
Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain
Yabuki, Y., Matsuo, K., Kawahata, I., Fukui, N., Mizobata, T., Kawata, Y., Owada, Y., Shioda, N., & Fukunaga, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062230 · Cited by 49 · see citing works
Malfertheiner, K., Stefanova, N., & Heras-Garvin, A. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.737195 · Cited by 46 · see citing works
Neuropathology of α‐synuclein in Parkinson's disease
Choong, C., & Mochizuki, H. (2022) · Neuropathology · doi:10.1111/neup.12812 · Cited by 49 · see citing works
Renner, H., Schöler, H. R., & Bruder, J. M. (2021) · Movement Disorders · doi:10.1002/mds.28775 · Cited by 47 · see citing works
A Summary of Phenotypes Observed in the In Vivo Rodent Alpha-Synuclein Preformed Fibril Model
Polinski, N. K. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212847 · Cited by 46 · see citing works
Spreading of alpha‐synuclein – relevant or epiphenomenon?
Killinger, B. A., & Kordower, J. H. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14779 · Cited by 45 · see citing works
Henderson, M. X., Covell, D. J., Chung, C. H.-Y., Pitkin, R. M., Frasier, R. M., Decker, S. C., Riddle, D. M., Zhang, B., Gathagan, R. J., James, M. J., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104712 · Cited by 46 · see citing works
Self-citationAlpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
Brembati, V., Faustini, G., Longhena, F., & Bellucci, A. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1197853 · Cited by 42 · see citing works
Cyclized NDGA modifies dynamic α-synuclein monomers preventing aggregation and toxicity
Daniels, M. J., Nourse, J. B., Kim, H., Sainati, V., Schiavina, M., Murrali, M. G., Pan, B., Ferrie, J. J., Haney, C. M., Moons, R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39480-z · Cited by 42 · see citing works
Yao, L., Lin, K., Zheng, Z., Koç, S., Zhang, S., Lu, G., & Skutella, T. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9235358 · Cited by 41 · see citing works
Genetic Imaging of Neuroinflammation in Parkinson’s Disease: Recent Advancements
Yao, L., Wu, J., Koç, S., & Lu, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.655819 · Cited by 39 · see citing works
High Glucosylceramides and Low Anandamide Contribute to Sensory Loss and Pain in Parkinson's Disease
Klatt‐Schreiner, K., Valek, L., Kang, J., Khlebtovsky, A., Trautmann, S., Hahnefeld, L., Schreiber, Y., Gurke, R., Thomas, D., Wilken‐Schmitz, A., et al. (2020) · Movement Disorders · doi:10.1002/mds.28186 · Cited by 40 · see citing works
α-Synuclein Strains: Does Amyloid Conformation Explain the Heterogeneity of Synucleinopathies?
Hoppe, S. O., Uzunoğlu, G., & Nussbaum-Krammer, C. I. (2021) · Biomolecules · doi:10.3390/biom11070931 · Cited by 37 · see citing works
Bantle, C. M., Rocha, S. M., French, C. T., Phillips, A. T., Tran, K., Olson, K. E., Bass, T. A., Aboellail, T., Smeyne, R. J., & Tjalkens, R. B. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113845 · Cited by 37 · see citing works
Henderson, M. X., Henrich, M. T., Geibl, F. F., Oertel, W. H., Brundin, P., & Surmeier, D. J. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105687 · Cited by 35 · see citing works
Self-citationCurrent insights and assumptions on α-synuclein in Lewy body disease
Leak, R. K., Clark, R. N., Abbas, M., Xu, F., Brodsky, J. L., Chen, J., Hu, X., & Luk, K. C. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02781-3 · Cited by 38 · see citing works
Self-citationMechanisms of Glucocerebrosidase Dysfunction in Parkinson’s Disease
Chatterjee, D., & Krainc, D. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168023 · Cited by 34 · see citing works
Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies
Rahayel, S., Tremblay, C., Vo, A., Mišić, B., Lehéricy, S., Arnulf, I., Vidailhet, M., Corvol, J.-C., the ICEBERG Study Group, Vidailhet, M., et al. (2023) · Brain · doi:10.1093/brain/awad044 · Cited by 33 · see citing works
Sensory neuropathy and nociception in rodent models of Parkinson's disease
Valek, L., Auburger, G. W. J., & Tegeder, I. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039396 · Cited by 33 · see citing works
Boi, L., Pisanu, A., Palmas, M. F., Fusco, G., Carboni, E., Casu, M. A., Satta, V., Scherma, M., Janda, E., Mocci, I., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228535 · Cited by 33 · see citing works
Lewy Body Disease Primate Model with α‐Synuclein Propagation from the Olfactory Bulb
Sawamura, M., Onoe, H., Tsukada, H., Isa, K., Yamakado, H., Okuda, S., Ikuno, M., Hatanaka, Y., Murayama, S., Uemura, N., et al. (2022) · Movement Disorders · doi:10.1002/mds.29161 · Cited by 33 · see citing works
Liu, D., Guo, J.-J., Su, J.-H., Svanbergsson, A., Yuan, L., Haikal, C., Li, W., Gouras, G., & Li, J.-Y. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00242-5 · Cited by 32 · see citing works
Sokratian, A., Zhou, Y., Tatli, M., Burbidge, K. J., Xu, E., Viverette, E., Donzelli, S., Duda, A. M., Yuan, Y., Li, H., et al. (2024) · Science Advances · doi:10.1126/sciadv.adq3539 · Cited by 32 · see citing works
Grathwohl, S. A., Quansah, E., Maroof, N., Steiner, J. A., Spycher, L., Benmansour, F., Durán-Pacheco, G., Siebourg‐Polster, J., Oroszlan‐Szovik, K., Remy, H., et al. (2021) · Free Neuropathology · doi:10.17879/freeneuropathology-2021-3326 · Cited by 32 · see citing works
Self-citationα-Synuclein-mediated neurodegeneration in Dementia with Lewy bodies: the pathobiology of a paradox
Simon, C. A., Soga, T., Okano, H. J., & Parhar, I. S. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00709-y · Cited by 33 · see citing works
Parkinson Disease Propagation Using MRI Biomarkers and Partial Least Squares Path Modeling
Pyatigorskaya, N., Yahia‐Cherif, L., Valabrègue, R., Gaurav, R., Gargouri, F., Ewenczyk, C., Galléa, C., Fernández-Vidal, S., Arnulf, I., Vidailhet, M., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000011155 · Cited by 31 · see citing works
Venezia, S., Kaufmann, W. A., Wenning, G. K., & Stefanova, N. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.09.007 · Cited by 31 · see citing works
Inflammation in Experimental Models of α ‐Synucleinopathies
Harms, A. S., Kordower, J. H., Sette, A., Arlehamn, C. S. L., Sulzer, D. L., & Mach, R. H. (2020) · Movement Disorders · doi:10.1002/mds.28264 · Cited by 30 · see citing works
Sekiya, H., Matsubara, T., Deture, M. A., & Dickson, D. W. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00900-6 · Cited by 30 · see citing works
Toxic Protein Spread in Neurodegeneration: Reality versus Fantasy
Kara, E., Marks, J. D., & Aguzzi, A. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.09.004 · Cited by 29 · see citing works
From Synaptic Protein to Prion: The Long and Controversial Journey of α-Synuclein
Heras‐Garvin, A., & Stefanova, N. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.584536 · Cited by 29 · see citing works
Butterfield, D. A., Favia, M., Spera, I., Campanella, A., Lanza, M., & Castegna, A. (2022) · Molecules · doi:10.3390/molecules27030951 · Cited by 28 · see citing works
ATH434 Reduces α‐Synuclein‐Related Neurodegeneration in a Murine Model of Multiple System Atrophy
Heras‐Garvin, A., Refolo, V., Schmidt, C., Malfertheiner, K., Wenning, G. K., BRADBURY, M. J., Stamler, D. A., & Stefanova, N. (2021) · Movement Disorders · doi:10.1002/mds.28714 · Cited by 27 · see citing works
Experimental Animal Models of Prodromal Parkinson’s Disease
Yamakado, H., & Takahashi, R. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230393 · Cited by 27 · see citing works
The olfactory bulb proteotype differs across frontotemporal dementia spectrum
Lachén‐Montes, M., González-Morales, A., Schvartz, D., Zelaya, M. V., Ausín, K., Fernández‐Irigoyen, J., Sánchez, J. C., & Santamaría, E. (2019) · Journal of Proteomics · doi:10.1016/j.jprot.2019.04.011 · Cited by 25 · see citing works
Johnson, M., Bergkvist, L., Stetzik, L. A., Steiner, J. A., Meyerdirk, L. K., Schulz, E., Wolfrum, E., Luk, K. C., Wesson, D. W., Krainc, D., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105513 · Cited by 25 · see citing works
Self-citationWeber, M. A., Kerr, G., Thangavel, R., Conlon, M. M., Gumusoglu, S. B., Gupta, K., Abdelmotilib, H., Halhouli, O., Zhang, Q., Geerling, J. C., et al. (2023) · Journal of Parkinson s Disease · doi:10.3233/jpd-230129 · Cited by 25 · see citing works
Drobny, A., Ngo, P. A., Neurath, M. F., Zunke, F., & López-Posadas, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.655123 · Cited by 24 · see citing works
Sharma, M., Kaur, J., Rakshe, S., Sharma, N., Khunt, D., & Khairnar, A. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00436-9 · Cited by 24 · see citing works
Intercellular transmission of alpha-synuclein
Wu, S., & Schekman, R. W. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1470171 · Cited by 24 · see citing works
Geertsma, H. M., Fisk, Z. A., Sauline, L., Prigent, A., Kurgat, K., Callaghan, S. M., Arenkiel, B. R., Mollenhauer, B., Schlossmacher, M. G., Stadelmann, C., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00672-8 · Cited by 20 · see citing works
Abdelgawad, A., Rahayel, S., Zheng, Y., Tremblay, C., Vo, A., Mišić, B., & Dagher, A. (2022) · Network Neuroscience · doi:10.1162/netn_a_00296 · Cited by 22 · see citing works
Mason, D. M., Wang, Y., Bhatia, T. N., Miner, K. M., Trbojevic, S., Stolz, J. F., Luk, K. C., & Leak, R. K. (2019) · Brain Pathology · doi:10.1111/bpa.12718 · Cited by 22 · see citing works
Self-citationSnca -GFP Knock-In Mice Reflect Patterns of Endogenous Expression and Pathological Seeding
Caputo, A., Liang, Y., Raabe, T. D., Lo, A., Horvath, M., Zhang, B., Brown, H. J., Stieber, A., & Luk, K. C. (2020) · eNeuro · doi:10.1523/eneuro.0007-20.2020 · Cited by 22 · see citing works
Self-citationHaikal, C., Ortigosa-Pascual, L., Najarzadeh, Z., Bernfur, K., Svanbergsson, A., Otzen, D. E., Linse, S. S., & Li, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111594 · Cited by 21 · see citing works
- Authors
- Rey, N. L., George, S., Steiner, J. A., Madaj, Z., Luk, K. C., Trojanowski, J. Q., Lee, V. M.-Y., & Brundin, P.
- Affiliations
- Van Andel Institute (US)
- University of Pennsylvania (US)
- Corresponding author
- Rey, Nolwen L.
- ORCID
- Venue
- Acta Neuropathologica
- Published
- 2017-12-05
- Volume
- 135
- Issue
- 1
- Pages
- 65-83
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC5756266
- OpenAlex
- W2774883898
- Cited by
- 215
- References
- 77
- Citations by year
- 2026: 13 · 2025: 20 · 2024: 17 · 2023: 18 · 2022: 25 · 2021: 41 · 2020: 39 · 2019: 29 · 2018: 10 · 2017: 2
- FWCI
- 15.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Van Andel Research Institute
- Peter C. and Emajean Cook Foundation
- National Institutes of Health (1R01DC016519-01, 5R21NS093993-02)
- Penn Morris K. Udall Parkinson's disease Research Center of Excellence (P50 NS053488)
- Penn Morris K. Undall Parkinson's Research Center of Excellence (P50 NS053488)
- Penn AD Core center (P30 AG10124, P01 AG17586)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
- Keywords
- alpha-synuclein fibrils, Parkinson's disease, olfactory bulb, transneuronal spread, synucleinopathies, neuronal loss, anterior olfactory nucleus, mitral cells, substantia nigra, neurodegeneration
- MeSH terms
- Animals, Biological Transport, Brain, Disease Models, Animal, DNA-Binding Proteins, Female, Humans, Mice, Inbred C57BL, Neurons, Olfactory Bulb, Recombinant Proteins, tau Proteins, Cell Death, Disease Progression, Neurodegenerative Diseases, alpha-Synuclein, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review